JCI - JAK inhibitors in autoinflammation
JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis - ScienceDirect
The molecular details of cytokine signaling via the JAK/STAT pathway - Morris - 2018 - Protein Science - Wiley Online Library
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Pathways: JAK-STAT Signaling | www.antibodies-online.com
JCI - The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
JAKs and STATs in Immunity, Immunodeficiency, and Cancer | NEJM
Understanding STAT3, the intersection of many carcinogenic signaling pathways
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
JAK/STAT signaling in hematological malignancies | Oncogene
IJMS | Free Full-Text | Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
Viruses | Free Full-Text | JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
APExBIO - JAK/STAT Signaling - Signaling Pathways
Current and future status of JAK inhibitors - The Lancet
Targeting the JAK/STAT pathway in solid tumors
Cells | Free Full-Text | Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
